Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
about
Role of liver transplantation in human immunodeficiency virus positive patientsHepatitis B and human immunodeficiency virus co-infectionEnhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individualsCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesPrevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SMK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A ProteaseAlcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsHigh Prevalence of Liver Fibrosis in Patients with Human Immunodeficiency Virus Monoinfection and Human Immunodeficiency Virus Hepatitis-B Co-infection as Assessed by Shear Wave Elastography: Study at a Teaching Hospital in KenyaIs antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency VirusMeta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort studyEvaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcomeSurvival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsViral hepatitis in HIV infection.Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10.Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients.Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans.High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda.HIV-1 Nef is transferred from expressing T cells to hepatocytic cells through conduits and enhances HCV replication.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.Drug trafficking routes and hepatitis B in injection drug users, Manipur, India.National Trend and Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched Case-Control Study-Taiwan, 2001-2014.Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast AsiaEvidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview
P2860
Q26775931-8589CFD2-4C3F-44E3-AA92-C4FC4F57CFAEQ26822862-E49B7856-1770-45D8-8BDC-1912F88A16FDQ27486399-9A842279-3B51-415D-BF66-F1EDABF209C2Q27488883-B9A2661F-226E-488F-88BC-B50CEDA99CE2Q27489610-F53DB60F-83C2-4387-8045-5BC7CAB25E75Q27490545-5B273839-EB6F-4AED-83DE-A0E12EBAE228Q28070280-0BECB5B7-03AD-4FF6-BB01-6A423C22FA47Q30379450-E4955D84-AE03-471D-8530-ED2375F5B143Q33410098-936C784F-118C-4AEA-8A4D-B6D29AF0AF16Q33430799-D04435E2-B76A-4618-A16B-930BA0FBCA6DQ33585762-EE5317EC-3BCB-40CE-BA41-2F1E6B87BCB3Q33802414-D7B524E4-633F-47B2-A5CE-D143D7C69BABQ33811374-77177A07-8C59-4EEA-B217-43F5DFCDC759Q33870620-4D419499-7E00-4B46-9F88-6AD7EBBB8331Q34026982-EBEA2879-E993-49FC-BBF7-6A81F6C3F90FQ34052838-F6778AE5-DC33-4E11-AB29-212078C94DB9Q34086980-F2152086-A4E9-48B6-A1EF-478BBAA74B50Q34157953-44658C33-E8D8-4896-8E71-0825C45EB10FQ34191840-1B6CC953-02B7-4A8D-96AA-926D6A430B45Q34218503-C5105E03-4A7C-42A3-A836-9BCC12C6FA94Q34367370-7A6077B3-BB02-4E6F-B108-840A46E82CB8Q34474434-F98DA5A5-94FA-49DA-B99A-451B60FBC714Q34758927-931A796F-1384-4697-B96A-2A76A31742E4Q34831090-CF0FBDAC-106D-4987-9444-F3B53D7D979AQ34844389-7B315201-44F2-4774-8D72-A6E168A4EDB7Q35050640-533648CC-7A0D-4B81-B51A-69328BAD5BD1Q35088330-236459DC-F9AA-4FB2-8240-680A4650BE00Q35125231-119D3689-D59C-46D0-891B-202D9068341AQ35184027-5D88F039-165C-441A-AD30-577DCE90D4B6Q35653358-541E5794-D0D0-4079-9F16-820B7B3E4B7EQ35685474-52CE316A-2B7C-434E-AA28-B6A5B489CA74Q35772764-18C85DA5-DB99-4C51-8152-A79B03CC89E6Q35780728-BB2D11B7-C92B-43D8-B249-8AF137A0F0EBQ35793581-159FDA16-EA74-457F-AE72-37E7DF386E79Q35800310-0CB181B1-8D78-43C4-AB13-6F2CFBBCE778Q35834104-36442400-D4C3-499F-801C-952BE10C3B12Q35980035-0F9AC8F5-213D-4E6C-921F-C4141C1905E0Q35980818-C26BE2B2-729C-4C12-B1BC-FC7002D8441AQ36034450-82CB966B-5B11-4178-907F-5620836D7ECEQ36063045-F0F9F950-B0D7-4AB7-9E11-2BA5F8DD7E4E
P2860
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Liver disease as a major cause ...... s C and B viruses and alcohol.
@en
Liver disease as a major cause ...... s C and B viruses and alcohol.
@nl
type
label
Liver disease as a major cause ...... s C and B viruses and alcohol.
@en
Liver disease as a major cause ...... s C and B viruses and alcohol.
@nl
prefLabel
Liver disease as a major cause ...... s C and B viruses and alcohol.
@en
Liver disease as a major cause ...... s C and B viruses and alcohol.
@nl
P2093
P1476
Liver disease as a major cause ...... s C and B viruses and alcohol.
@en
P2093
Charlotte Lewden
Dominique Salmon-Ceron
Eric Jougla
Fabrice Bonnet
Laurence Héripret
Mortality 2000 study group
Philippe Morlat
Sibylle Bévilacqua
Thierry May
P304
P356
10.1016/J.JHEP.2005.01.022
P577
2005-06-01T00:00:00Z